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ABSTRACT
Background and Objectives: Obesity is a major comor-
bidity in the Western world and influences outcomes of
patient care. A minimally invasive approach towards rad-
ical cystectomy has been increasing in popularity. We
sought to determine the influence of body mass index
(BMI) on robot-assisted radical cystectomy.
Methods: Fifty-one consecutive patients underwent ro-
bot-assisted radical cystectomy for bladder cancer from
October 2005 to April 2007 and were categorized into 3
groups based on their weight: normal (BMI 25), over-
weight (BMI25 to 29) and obese (BMI 30 to 39.9).
Effect of BMI on intraoperative, pathologic, and postop-
erative outcomes was assessed by retrospective review of
the robot-assisted radical cystectomy database.
Results: Mean BMI was 28.0, and 71% of the patients
were overweight or obese. BMI did not correlate with age,
sex, or American Society of Anesthesiologists (ASA) score.
Overweight and obese patients had similar operative
times and estimated blood loss compared with patients
with normal BMI. Overweight and obese patients with
bulky disease (pT3–4) had significantly higher rates of
positive surgical margins (P0.05). Complication rates
were similar.
Conclusion: Robotic-assisted radical cystectomy can be
considered for patients of all body mass indices. Wider
excision should be performed in patients with higher BMI.
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INTRODUCTION
Obesity has emerged as a major healthcare problem in the
United States and a common comorbid factor in surgical
patients. Data from the two National Health and Nutrition
Examination Surveys (NHANES) demonstrate that the
prevalence of obesity increased from 15.1% in 1980 to
31.1% in 2002 among patients 20 to 74 years of age.1
Elevated BMI has been thought to be associated with
poorer surgical outcomes, especially after procedures of
increased technical complexity. Numerous studies have
classified overweight and obese individuals into higher
preoperative risk categories. Chang et al2 reported in-
creased perioperative blood loss and prolonged operative
times in patients with elevated BMI undergoing open
radical cystectomy.
In the current study, the affect of elevated BMI on intra-
operative parameters and postoperative and pathologic
outcomes was evaluated in 51 consecutive patients who
underwent robot-assisted radical cystectomy.
METHODS
An institutional review board-approved retrospective
chart analysis was performed of 51 consecutive patients
who underwent robot-assisted radical cystectomy for car-
cinoma of the bladder from October 2005 to April 2007.
All patients were offered open radical cystectomy or ro-
bot-assisted radical cystectomy, and all chose the robotic
procedure. Data were collected prospectively using med-
ical record committee-approved forms and entered into a
database required as part of an institutional quality assur-
ance initiative. Appropriate patients were given the choice
of orthotopic continent diversion, cutaneous continent
diversion, and ileal conduit urinary diversion. All diver-
sions were performed in extracorporeal fashion, except
for one neobladder that was created robotically. Patients
were divided into 3 cohorts: normal weight (BMI 25),
overweight (BMI25 to 29) and obese (BMI30 to 39.9)
for the purpose of comparison. The effect of BMI on
preoperative variables, intraoperative parameters and
early postoperative results was evaluated.
Binary variables were summarized by calculating frequen-
cies and relative frequencies. Fisher’s exact test was used
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SCIENTIFIC PAPERto study the association between categorical variables and
BMI group. Numeric variables were summarized using
means and standard deviations. The Kruskal-Wallis test
was used to compare BMI group and numeric variables.
Secondary analyses, based on ungrouped BMI values,
were performed using either the exact test corresponding to
the Spearman rank correlation or logistic regression depend-
ing on the nature of the outcome variables. A 0.05 nominal
significance level was used in all testing. All statistical
analyses were carried out using SAS (version 9.1).
RESULTS
Mean BMI was 28, and 71% of the patients were over-
weight or obese. Two patients were converted to an open
cystectomy: one patient was unable to tolerate a steep Tren-
delenberg position and one patient had a large posterior
tumor extending into the rectum. Three fourths of patients
were male, and sex distribution was similar in each BMI
group. Age and ASA scores were similar across groups with
mean age 67 and mean ASA score 2.3 (Table 1).
The mean operative time from incision to bladder extir-
pation was 180 minutes. A trend was found towards de-
creased extirpation time in patients with elevated BMI.
The time to create a urinary diversion was proportional to
the BMI. The mean operative time for pelvic lymph node
dissection was 44 minutes and was similar in all cohorts.
No intraoperative complications were seen. Mean blood
loss was 546.4 mL. Blood loss varied among the 3 groups
but did not correlate with BMI (Table 2).
Twenty-one patients had organ-confined bladder cancer,
18 patients had tumor extending into perivesical adipose
tissue, and 10 patients had tumor extending into sur-
rounding organs. No significant difference was noted in
the primary tumor stage between the 3 groups. Six pa-
tients (12%) had positive surgical margins. Five positive
surgical margins occurred in the overweight cohort, and
one positive margin occurred in the obese cohort
(P0.05). All pathologic stage T0-T2 patients had negative
surgical margins. Two surgical margins were positive
(11%) in pT3 patients, and 4 (40%) surgical margins were
positive in pT4 patients. The greatest numbers of lymph
nodes were extracted from obese patients, but no signif-
icant difference existed among the 3 groups.
Thirteen postoperative complications occurred; 3 devel-
oped in the normal weight cohort, 6 in the overweight
cohort, and 4 in the obese cohort (P0.77). One death
occurred in the overweight group (Table 4).
DISCUSSION
Obese patients have increased risk for multiple medical
problems that can adversely affect surgical outcomes. In
the Common Toxicity Criteria for Adverse Events of the
Cancer Therapy Evaluation Program, being overweight
(BMI25) is graded as a moderate risk of an adverse
event, obesity (BMI30 to 39.9) is graded as a severe risk,
and morbid obesity (BMI40) is considered life threaten-
ing.3 Obesity with or without comorbidities can lead to
deranged cardiovascular physiology leading to eccentric
left ventricular hypertrophy that significantly increases the
risk for future perioperative cardiovascular events, such as
acute myocardial ischemia, myocardial infarction, conges-
tive heart failure, and sudden death.4–6 These events are
even more pronounced when hypertension is present.7
Pulmonary compromise can predispose the obese patient
to pneumonia and atelectasis.8,9 Several series have re-
ported an increased incidence of obesity in patients with











Age 67 (12) 68 (13) 69 (13) 65 (9)
Sex
Male 37 (76) 8 (57) 15 (83) 14 (82)
Female 12 (25) 6 (43) 3 (17) 3 (18)
ASA Score 2.3 (0.5) 2.1 (0.4) 2.4 (0.5) 2.4 (0.5)
Previous Abdominal/Pelvic Surgery 30 (61) 8 (57) 13 (72) 9 (53)
*For numerical variables, statistics represent mean (SD); for categorical variables, statistics represent frequency (relative frequency).
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infections, have been reported in obese patients.11,12
Numerous investigators have reported on the affect of an
elevated BMI on various minimally invasive surgical pro-
cedures. Singh et al13 reported increased blood loss and
operative times during laparoscopic prostatectomy in pa-
tients with elevated BMI. Mikhail et al14 reported similar
findings in a study of 150 patients who underwent robotic
prostatectomy. Dominguez et al15 revealed longer opera-
tive times and higher blood loss in patients with elevated
BMI during laparoscopic splenectomy. However, other
investigators did not find a significant difference in out-
comes when operating on overweight or obese patients.
Colombo et al16 demonstrated that BMI had no significant
impact on outcomes after laparoscopic nephrectomy. Ro-
bot-assisted prostatectomy data from the Australian Insti-
tute of Robotic Surgery suggest that vesicourethral anas-
tomotic times were greater in obese patients, but the
overall operative times were similar regardless of BMI. Fur-
thermore, the overall complication rates from the Australian
series were similar during the immediate postoperative pe-
riod.17 Boczko et al18 reported similar findings in 375 patients
who underwent robot-assisted radical prostatectomy.
Two large series specifically investigated the impact of
elevated BMI on open radical cystectomy. Chang et al2
reported that overweight and obese patients had elevated
blood loss and longer operative times during open radical
cystectomy. In their series, there was no difference in the
complication rate among the different cohorts. Lee et al19













a. Incision RRC‡ 180 (63) 192 (57) 178 (57) 172 (74) 0.40
b. PLND‡ 44 (13) 40 (8) 45 (18) 45 (12) 0.46
c. Diversion 142 (96) 127 (36) 143 (123) 154 (100) 0.79
No. of Diversion Types
a. Ileal Conduit 46 (94) 14 (100) 16 (89) 16 (94 0.78
b. Neobladder 3 (6) 0 (0.0) 2 (11) 1 (6)
Open Conversion 2 (4) 0 (0) 1 (6) 1 (6) 1.0
Intraoperative Complication 0 0 0 0 1.0
Blood Loss 546 (437) 630 (620) 496 (365) 532 (332) 0.81
*For numerical variables, statistics represent mean (SD); for categorical variables, statistics represent frequency (relative frequency).












Organ Confined/pT0-pT2 21 (43) 9 (64) 5 (28) 7 (41)
Nonorgan Confined 0.25
pT3 18 (37) 4 (29) 9 (50) 5 (29)
pT4 10 (20 1 (7) 4 (22) 5 (29)
Positive Surgical Margins 6 (12) 0 (0.0) 5 (28) 1 (6) 0.05
Number of nodes 17 (9) 16 (6) 16 (9) 18 (11) 0.81
*For numerical variables, statistics represent mean (SD); for categorical variables, statistics represent frequency (relative frequency).
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BMI in their open radical cystectomy series.
The current series is the first to evaluate the effect of BMI
on robot-assisted radical cystectomy. Unlike the results
reported by Chang et al2 and Lee et al,19 operative time,
blood loss, and the complication rate did not significantly
differ among the 3 cohorts in our series, demonstrating the
decreased impact of elevated BMI on the performance of
robot-assisted radical cystectomy. Robot-assisted bladder
extirpation was quicker in patients with BMI greater than
25, while extracorporeal urinary diversion took longer in
obese and overweight patients (P0.05). The overall op-
erative time was similar among the 3 groups. Obese pa-
tients had lower blood loss than patients with normal BMI
(P0.81). The complication rates were similar across the 3
groups (P1.0).
The only adverse affect of elevated BMI was an increase in
the rate of positive surgical margins (P0.05). All patients
with a normal BMI had negative surgical margins. All
positive margins occurred in patients with pT3 or pT4
disease and 4 of the 6 patients with positive margins had
nodal metastasis. The positive margin rate of 21% in pa-
tients with bulky tumors (pT3–4) was higher than the 12%
positive margin rate for bulky disease noted by Herr et
al.20 Hafron et al21 demonstrated that while soft tissue
margins impact overall survival, no significant difference
in disease-specific survival or overall survival was seen in
obese, overweight, and normal weight patient popula-
tions.
Limitations of our study included a small population size.
Only 49 patients underwent robot-assisted radical cystec-
tomy. However, to our knowledge, no large robot-assisted
radical cystectomy series have been published to date.
Another limitation is the retrospective nature of our study
and the lack of a prospective, randomized comparison
with open radical cystectomy. The analysis was per-
Table 4.









Hospital Stay (Days) (SD) 9.4 (8.7) 11.8 (13.5) 7.7 (3.3) 9.1 (7.6)
Complications Rate (%) 13 (27) 3 (21) 6 (33) 4 (24)
Complications
Dysrhythmia 1 1 0 0
Myocardial Infarction 1 0 1 0
Pulm Embolism/DVT 2 0 0 2
Renal failure 1 0 1 0
Wound Infection 1 1 0 0
Wound Dehiscence 1 1 0 0
Ureteral Stricture 1 1 0 0
Rectal Injury 0 0 0 0
Vascular Injury 0 0 0 0
Postop Hemorrhage 2 0 2 0
Postop Infection (C. difficile)1 1 0 0
Sepsis 2 1 1 0
Ileus 1 1 0 0
Pneumonia 0 0 0
UTI 1 0 1 0
PSBO/SBO 3 0 1 2
Mortality 1 0 0 1
DVTdeep venous thrombosis, UTIurinary tract infection, PSBOpartial small bowel obstruction, SBOsmall bowel obstruction, C.
difficileClostridium difficile
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spectively as part of an institutional quality assurance
initiative.
CONCLUSIONS
Robotic-assisted radical cystectomy can be considered in
patients with elevated BMI because complication rates,
operative times, and blood loss were similar in patients
from the average, overweight, and obese BMI categories.
Our data suggest that wider surgical excision is needed in
patients with elevated BMI to decrease the risk of a pos-
itive surgical margin.
Centers for Disease Control and Prevention (CDC). Na-
tional Center for Health Statistics (NCHS). National Health
and Nutrition Examination Survey Data, Hyattsville, MD:
U.S. Department of Health and Human Services, Centers
for Disease Control and Prevention, 1999–2002. Accessi-
bility verified August 14, 2007. Available at: http://www.
cdc.gov/nchs/about/major/nhanes/datalink.htm.
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